These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25990531)

  • 21. [Myasthenia gravis in adults of institutions pertaining to the Mexican public health system: an analysis of hospital discharges during 2010].
    Tolosa-Tort P; Chiquete E; Domínguez-Moreno R; Vega-Boada F; Reyes-Melo I; Flores-Silva F; Sentíes-Madrid H; Estañol-Vidal B; García-Ramos G; Herrera-Hernández M; Ruiz-Sandoval JL; Cantú-Brito C
    Gac Med Mex; 2015; 151(1):47-53. PubMed ID: 25739484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood onset myasthenia gravis.
    Raksadawan N; Kankirawatana P; Balankura K; Prateepratana P; Sangruchi T; Atchaneeyasakul LO
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S769-77. PubMed ID: 12403259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
    Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
    Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of myasthenia gravis in northwestern Sardinia.
    Aiello I; Pastorino M; Sotgiu S; Pirastru MI; Sau GF; Sanna G; Rosati G
    Neuroepidemiology; 1997; 16(4):199-206. PubMed ID: 9267837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.
    Kalb B; Matell G; Pirskanen R; Lambe M
    Neuroepidemiology; 2002; 21(5):221-5. PubMed ID: 12207149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.
    Cetin H; Fülöp G; Zach H; Auff E; Zimprich F
    Wien Klin Wochenschr; 2012 Nov; 124(21-22):763-8. PubMed ID: 23129486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of myasthenia gravis among rural adult populations.
    Nemet AY; Kaiserman I; Mimouni M; Segal O; Vinker S
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):47-50. PubMed ID: 25415514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular Manifestations.
    Peragallo JH; Bitrian E; Kupersmith MJ; Zimprich F; Whittaker TJ; Lee MS; Bruce BB
    J Neuroophthalmol; 2016 Mar; 36(1):29-32. PubMed ID: 26035808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis on the Dutch antilles: an epidemiological study.
    Holtsema H; Mourik J; Rico RE; Falconi JR; Kuks JB; Oosterhuis HJ
    Clin Neurol Neurosurg; 2000 Dec; 102(4):195-198. PubMed ID: 11154803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
    Lai CH; Tseng HF
    Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
    Andersen JB; Heldal AT; Engeland A; Gilhus NE
    Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the prevalence of familial autoimmune myasthenia gravis in a Spanish cohort.
    Salvado M; Canela M; Ponseti JM; Lorenzo L; Garcia C; Cazorla S; Gili G; Raguer N; Gamez J
    J Neurol Sci; 2016 Jan; 360():110-4. PubMed ID: 26723985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical feature of late-onset myasthenia gravis].
    Minami N
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():495-500. PubMed ID: 26480748
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977-2015.
    Martinka I; Fulova M; Spalekova M; Spalek P
    Neuroepidemiology; 2018; 50(3-4):153-159. PubMed ID: 29558746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia gravis in children: a longitudinal study.
    Ashraf VV; Taly AB; Veerendrakumar M; Rao S
    Acta Neurol Scand; 2006 Aug; 114(2):119-23. PubMed ID: 16867035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China.
    Fang W; Li Y; Mo R; Wang J; Qiu L; Ou C; Lin Z; Huang Z; Feng H; He X; Wang W; Xu P; Wang L; Ran H; Liu W
    Neurol Sci; 2020 May; 41(5):1211-1223. PubMed ID: 31897952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Some epidemiological aspects of myasthenia gravis in Cuba].
    Cisneros AD; Luis RS; León R; Carrera PL
    Rev Neurol; 1996 Apr; 24(128):435-9. PubMed ID: 8721922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myasthenia gravis: epidemiology and prognosis].
    Murai H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():472-6. PubMed ID: 26480744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.